RCS - Hygea VCT plc - Scancell to present at Biotech Capital <Origin Href="QuoteRef">HYG.L</Origin>

Seneca Growth Capital VCTAnnouncement

24/02/2016 10:50

RNS Number : 0084Q
Hygea VCT plc
24 February 2016
For immediate release  24 February 2016
Hygea vct plc
Scancell plc to present at Biotech Capital in London on 3rd March 2016
The Board of Hygea vct plc announces that Hygea's largest investment by value, Scancell plc (www.scancell.co.uk), is presenting at the Biotech Capital Conference being held in London on 3rd March 2016. Attendance is free, with registration via www.biotech-capital.com/conferences - a recording of the event will be posted on the website. An article Immunotherapy: a turning point in cancer treatment by Vadim Alexandre can be found on page 8 of the AIM Journal (http://www.hubinvest.com/AIMPDFFebruary2016_77.pdf).
Enquiries:Charles Breese, director on 01280 703482

This information is provided by RNS
The company news service from the London Stock Exchange
  END
NRAUSSRRNAAUUAR